A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Prospects of monoclonal antibodies in COVID-19 treatment: a systematic review
[post]
2020
unpublished
We reviewed the types of monoclonal antibodies being repurposed for COVID-19 therapeutics, the clinical outcomes and adverse effects so as to provide evidence the bedside physicians, the health policy-makers and the general public could employ in the COVID-19 management protocol. This systematic review was conducted following the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The Joanna Briggs Institute's critical appraisal checklists for evaluation of the
doi:10.22541/au.159358932.20317539
fatcat:5iuimgrnlrgl3n4zhnurqaacoi